An observational cohort study uses multi-omics profiling to identify distinct biomarkers that could aid in the earlier ...

RA is an autoimmune disease where the immune system mistakenly attacks the lining of joints, causing inflammation and potential joint damage. Treatment goals for RA include reducing inflammation and ...

Rheumatoid arthritis (RA) is one of the more common autoimmune disorders, affecting approximately 1% of the population worldwide. The exact cause of RA is not known; however, initiation of disease ...

Several factors — but not older age — increased infection risk with the use of non-TNF biologics following first-line ...

Symptoms like inflammation, joint pain, and stiffness are an inevitable part of aging. But for about 1% of the population, these symptoms are signs of something different: rheumatoid arthritis.

Antibodies to peptides not currently used for rheumatoid arthritis (RA) diagnosis helped identify patients with untreated early disease that conventional biomarkers missed, researchers said. Almost ...

OA guidelines recommend surgery in patients with extensively impaired function and pain that is refractory to medication therapy. 17 RA guidelines suggest surgery in patients experiencing intolerable ...

For Stacy Courtnay, it all started with her stilettos. When she began experiencing intense foot pain twenty years ago, she attributed it to frequently wearing the towering, skinny-heeled shoes. "I ...

CHICAGO -- Hitting rheumatoid arthritis (RA) early and hard, with targeted therapies as first-line treatment, appears to ...

Polymyalgia rheumatica (PMR) and rheumatoid arthritis (RA) are both autoimmune conditions that involve the immune system attacking the joints. While both conditions share symptoms like joint pain and ...

More than just a condition that causes achy joints, rheumatoid arthritis (RA) is a chronic inflammatory disorder that can affect a person’s life in profound ways. People with RA seesaw between periods ...

A biomarker panel for IPF may identify RA patients at higher risk for ILD, supporting biological overlap between IPF and ...